NIVF NewGenIvf Group Limited
USHealthcareAs of 2026-08-24
Why NIVF matters now
NewGenIvf Group Limited (NIVF) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.49 with -14.93% on the session and $93.8K in market capitalization; recent performance reads 1-month -12.02% and YTD -90.85%.
The latest financial table shown here is Q4 2025, with revenue of $1.4M, net income of $-7.7M, and EPS of $-13.04. Investors can compare that operating picture with valuation signals such as P/E 0.07 and FCF yield -1476.1%.
The latest indexable market news headline is "NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is available with a median target of $—; recent insider activity includes Chung Ho Fai filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
0.07
PEG
0.00
P/B
0.02
P/S
0.16
EV/EBITDA
0.48
DCF Value
$-7.34
FCF Yield
-1476.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.7%
Operating Margin
-276.6%
Net Margin
338.2%
ROE
32.7%
ROA
28.0%
ROIC
-24.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.4M | $-7.7M | $-13.04 |
| FY 2025 | $4.7M | $9.9M | $16.80 |
| Q3 2025 | $1.3M | $16.8M | $28.60 |
| Q4 2024 | $1.3M | $-108.0K | $-4.60 |
Analyst Ratings
Consensus
—
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
TH
Exchange
—
Beta
-0.08
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.